Our study showed that transketolase activity was significantly reduced in NRF2-knockdown HNSCC cells and xenograft tumors (Figure 5, Figure S15), and NRF2 did not affect the expression of TKTL1 or TKTL2 gene in HNSCC (data not shown). The gene discussed is TKT; the disease is head and neck squamous cell carcinoma.